Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

1,038 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Delhi High Court Sought Explanation Through Counter Affidavit Over Repudiation Of Patent Application For Xtandi

    Xtandi, the wonder drug for prostate cancer, was developed at UCLA, Los Angeles, by the innovation of NIH and Department of Defense grants.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    From Public Domain To Patenting: Evolution Of Policies And Practices In Publicly Funded Pharmaceutical Research

    The concept of patenting pharmaceutical innovations has been always a point of debate in the academic community.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    IP Protection In The Cosmetics Industry

    Any talk about cosmetics is incomplete without a discussion about their side effects on the human body. The concern about safety is embedded in cosmetics...
    IndiaIntellectual Property
    Sujata Chaudhri IP Attorneys
    Sujata Chaudhri IP Attorneys
  • Article

    Agro Tech Foods Limited, Final Order No. A/30508/2025 Dated 21.11.2025, CESTAT Hyderabad

    The issue before the Hon'ble Bench of the Customs, Excise & Service Tax Appellate Tribunal at Hyderabad was regarding eligibility of credit of CVD paid on import of Peanut Butter which was utilised towards excise duty ...
    IndiaLitigation, Mediation & Arbitration
    Lakshmikumaran & Sridharan
    Lakshmikumaran & Sridharan
  • Article

    EMA Modernizing The Orphan Designation Process

    IRIS is the online web portal through which applicants can apply to the EMA for orphan designation for a medicine.
    European UnionFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    European Medicines Agency (EMA) Recommends Approval Of Six Medicines In Its October Meeting

    Flucelvax Tetra will be available as a suspension for injection in pre-filled syringes.
    European UnionFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    APEDA Adjudication Of Penalties Rules 2026: A Complete Breakdown Of The New Compliance Framework

    The Indian export ecosystem for agricultural and processed food products has seen a significant regulatory update with the notification of fresh adjudication rules. The Central Government, acting through the Ministry of Commerce and Industry, issued these rules by invoking its powers under clauses (ma) and (mb) of sub-section (2) of section 32, read together with section 25A of the Agricultural and Processed Food Products Export Development Authority Act of 1985.
    IndiaCompliance
    IndiaLaw LLP
    IndiaLaw LLP
  • Article

    Indian FSSAI’s New Labelling Rules 2026

    India's food safety regulator has introduced new labelling amendments that simplify compliance for infant nutrition products and small packages while strengthening traceability requirements for non-retail containers. Meanwhile, the Supreme Court is pushing for front-of-pack warning labels on products high in fat, sugar, and salt, raising critical questions about implementation thresholds, consumer accessibility, and the balance between public health and industry concerns.
    IndiaConsumer Protection
    Global Advertising Lawyers Alliance (GALA)
    Global Advertising Lawyers Alliance (GALA)
  • Article

    Legalaxy – Monthly Newsletter Series – Vol XIII – June, 2024

    In the June edition of our monthly newsletter "Legalaxy", our team analyses some of the key developments in securities market, banking and finance, renewable energy and pharmaceuticals.
    IndiaCorporate/Commercial Law
    Vaish Associates Advocates
    Vaish Associates Advocates
  • Article

    Bail Under The Narcotic Drugs And Psychotropic Substances Act (NDPS Act)

    The Narcotic Drugs and Psychotropic Substances Act, 1985 ("the NDPS Act") is one of the strictest criminal laws in the country. Section 37 of the NDPS Act restricts...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Kochhar & Co.
    Kochhar & Co.
  • Article

    Biosimilars- An Emerging Trend In Indian Pharma Industry

    India released the draft regulatory guidelines for ‘Similar Biologics' at the BIO industry conference in Boston, USA, on 19 June 2012.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Lex Orbis
    Lex Orbis
  • Article

    CCI For Affordable Healthcare

    The advancement in science has extended the life span of the individuals by means of life saving medications.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    CDSCO Approves Macitentan For The Treatment Of Pulmonary Arterial Hypertension (PAH)

    The Central Drugs Standard Control Organization (CDSCO) is the Central Drug Authority for discharging functions assigned to the Central Government under the Drugs and Cosmetics Act, 1940 and Rules, 1945.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Central Government To Increase Regulatory Fee For Various Drug Licensing Activities

    On October 5, 2018, the Central Government, in consultation with the Drugs Technical Advisory Board, proposed rules to amend Drugs and Cosmetics Rules, 19451 (D&C Rules, 1945) with an intention to revise fee ...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Centre Proposes Draft e-Pharmacy Rules To Regulate Online Sale Of Drugs

    On August 28, 2018, the Central Government proposed ePharmacy draft rules under Drugs and Cosmetics Act 1945.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Cosmeceuticals And The Limits Of Classification Under Indian Law

    The rapid expansion of India's skincare and personal care sector has brought renewed attention to a category of products commonly referred to as "cosmeceuticals" being formulations that straddle the conceptual boundary between cosmetics and pharmaceuticals.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Legitpro Law
    Legitpro Law
  • Article

    Delhi High Court Promotes Indigenous R&D In The Pharmaceutical Industry: Novel Drug Delivery Systems Are Not Implicitly Included Under The Drugs (Price Control) Order, 2013

    In the recent case of Modi-Mundipharma Private Limited v Union of India & Ors., (Writ Petition (Civil) No. 11802 of 2016), the High Court of Delhi has clarified that incremental innovation...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Khaitan & Co.
    Khaitan & Co.
  • Article

    Department Of Pharmaceuticals (DoP) Has Invoked The Powers Under Paragraph 3 Of Drugs Prices Control Order, 2013

    NPPA, a regulatory body under Department of Pharmaceuticals, Government of India, is authorized to fix/ revise the prices of controlled bulk drugs and formulations and to enforce prices...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    FSSAI Guidelines For Restaurants/FBOs Amid COVID-19

    Food has been an indispensable requirement for human life and caters ample opportunity to those engaged in commercializing the same.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    FSSAI-Loose Sweets To Have Manufacturing Date And Best Before Date

    The Food Safety and Standards Authority of India on February 24, 2020 issued an Order directing all Food Business Operators of non-packaged/ loose sweets to display the labels comprising ‘Date of Manufacturing' and ...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Showing 341–360 of 1038 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics